Raymed Labs Ltd. | Income Statement
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Cost of Goods Sold (COGS) incl. D&A
187.40
100.00
89.60
71.30
-
64
Gross Income
187.40
100.00
89.60
71.30
-
64
SG&A Expense
152.40
298.80
252.90
319.40
332.00
303
EBIT
339.80
398.80
342.60
390.70
400.00
367
Unusual Expense
349.20
-
225.00
229.00
288.00
-
Non Operating Income/Expense
196.50
216.00
192.00
120.00
120.00
169
Pretax Income
492.50
182.80
375.60
499.70
568.00
535
Consolidated Net Income
492.50
182.80
375.60
499.70
568.00
535
Net Income
492.50
182.80
375.60
499.70
568.00
535
Net Income After Extraordinaries
492.50
182.80
375.60
499.70
568.00
535
Net Income Available to Common
492.50
182.80
375.60
499.70
568.00
535
EPS (Basic)
0.12
0.04
0.09
0.12
0.13
0.12
Basic Shares Outstanding
4,273.50
4,273.50
4,273.50
4,273.50
-
-
EPS (Diluted)
0.12
0.04
0.09
0.12
-
-
Diluted Shares Outstanding
4,273.50
4,273.50
4,273.50
4,273.50
-
-
EBITDA
320.40
-
252.90
319.40
332.00
303
About Raymed Labs
View Profile
